Clincosm LogoSign in Get a demo

transthyretin amyloid cardiomyopathy

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Age-Linked CArdiac TransThyRetin Amyloidosis by Selective

Not yet recruiting
  • Transthyretin Amyloid Cardiomyopathy
    • (no location specified)
    Oct 25, 2023

    Learn About Tafamidis in Transthyretin Amyloid Cardiomyopathy in

    Not yet recruiting
    • Transthyretin Amyloid Cardiomyopathy
    • (no location specified)
    Oct 11, 2023

    Transthyretin Amyloid Cardiomyopathy, Heart Failure Trial in Aarhus (Echocardiography)

    Active, not recruiting
    • Transthyretin Amyloid Cardiomyopathy
    • Heart Failure
    • Echocardiography
    • Aarhus, Denmark
      Aarhus University Hospital
    May 31, 2023

    Transthyretin Amyloid Cardiomyopathy Trial in China (Tafamidis)

    Active, not recruiting
    • Transthyretin Amyloid Cardiomyopathy
    • Beijing, Beijing, China
    • +8 more
    Dec 14, 2022

    Transthyretin Amyloid Cardiomyopathy, Heart Failure With Preserved Ejection Fraction Trial in Worldwide (Scintigraphy)

    Recruiting
    • Transthyretin Amyloid Cardiomyopathy
    • Heart Failure With Preserved Ejection Fraction
    • Scintigraphy
    • Fairhope, Alabama
    • +31 more
    Jul 21, 2022

    Transthyretin Amyloid Cardiomyopathy Trial in New York (Empagliflozin)

    Recruiting
    • Transthyretin Amyloid Cardiomyopathy
    • New York, New York
      Columbia University Irving Medical Center / NewYork-Presbyterian
    Mar 15, 2022

    Amyloidosis, Transthyretin Amyloid Cardiomyopathy Trial in Portland (99m-technetium pyrophosphate scintigraphy)

    Recruiting
    • Amyloidosis
    • Transthyretin Amyloid Cardiomyopathy
    • 99m-technetium pyrophosphate scintigraphy
    • Portland, Oregon
      Oregon Health & Science University
    Feb 17, 2022